sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Enzyme Replacement Therapy Market Scope And Analysis

  • Report Code : TIPRE00008474
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 226
Buy Now

Enzyme Replacement Therapy Market Analysis and Share - 2031

Buy Now

Enzyme Replacement Therapy Market Report Enzyme Replacement Therapy Market Size and Share Enzyme Replacement Therapy Market Scope and Analysis

Enzyme Replacement Therapy Market Report Scope

Report Attribute Details
Market size in 2021 US$ 9.67 Billion
Market Size by 2028 US$ 15.18 Billion
Global CAGR (2021 - 2028) 6.8%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Enzyme Type
  • Alglucosidase Alfa
  • Agalsidase Beta
  • Imiglucerase
  • Idursulfase
  • Galsulfase
  • Velaglucerase Alfa
  • Other Enzymes
By Therapeutic Conditions
  • Gaucher's Disease
  • Fabry's Disease
  • MPS
  • Pompe's Disease
  • SCID
  • Other Therapeutic Conditions
By Route of Administration
  • Parenteral and Oral
By End User
  • Hospitals
  • Infusion Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Sanofi
  • BioMarin Pharmaceutical Inc
  • Takeda Pharmaceutical Company Limited
  • AbbVie Inc
  • Janssen Pharmaceuticals Johnson Johnson Services Inc
  • Alexion Pharmaceuticals Inc AstraZeneca
  • Amicus Therapeutics
  • Recordati S p A
  • CHIESI Farmaceutici S p A